Immunology of normal pregnancy

Seminars in Fetal and Neonatal Medicine

Volumn 11, Issue 5, 2006, Pages 279-295

  Aagaard Tillery, Kjersti M ^a   Silver, Robert ^a   Dalton, Jess ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Cytokines; Human; Immune response; Immunology; Leukocytes; Placenta; Pregnancy

Indexed keywords

COLONY STIMULATING FACTOR; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA G ANTIGEN; INTERLEUKIN 3;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CYTOKINE PRODUCTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMPLANTATION; INNATE IMMUNITY; LARGE GRANULAR LYMPHOCYTE; LEUKOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MITOTIC RECOMBINATION; NATURAL KILLER CELL; NONHUMAN; PHYSICIAN; PREGNANCY; REPRODUCTION; SPONTANEOUS ABORTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; CYTOKINES; FEMALE; FETUS; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNITY, NATURAL; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MATERNAL-FETAL EXCHANGE; PREGNANCY; T-LYMPHOCYTES; TROPHOBLASTS;

EID: 33745957380     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2006.04.003     Document Type: Article

References (176)

1. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., and Schatz D.G. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 18 (2000) 495-527
2. Aagaard-Tillery K.M., and Jelinek D.F. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 156 (1994) 493-507
3. Aagaard-Tillery K.M., and Jelinek D.F. Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. J Immunol 156 (1996) 4543-4554
4. Aagaard-Tillery K.M., and Jelinek D.F. A role for phosphatidylinositol 3-kinase in generating T cell help for B cell growth and differentiation. J Immunol 157 (1996) 2769-2778
5. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339 (1989) 27-30
6. Nunez C., Nishimoto N., Gartland G.L., Billips L.G., Burrows P.D., Kubagawa H., et al. B cells are generated throughout life in humans. J Immunol 156 (1996) 866-872
7. Peault B. In-vitro models of stroma-dependent lymphopoiesis. Semin Immunol 7 (1995) 169-175
8. Tarlinton D. B-cell differentiation in the bone marrow and the periphery. Immunol Rev 137 (1994) 203-229
9. Jerne N. The natural-selection theory of antibody formation. Proc Natl Acad Sci USA 4 (1955) 849
10. Burnet M. The clonal selection theory of acquired immunity (1959), Vanderbuilt University Press, Nashville, TN p 209.
11. Tonegawa S. Somatic generation of antibody diversity. Nature 302 (1983) 575-581
12. Nemazee D., and Buerki K. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci USA 86 (1989) 8039-8043
13. Aagaard-Tillery K.M., and Jelinek D.F. Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosis. J Immunol 155 (1995) 3297-3307
14. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (1993) 990-993
15. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72 (1993) 291-300
16. Robey E., and Schlissel M. Lymphocyte development. Curr Opin Immunol 15 (2003) 155-157
17. Von Boehmer H., Aifantis I., Gounari F., Azogui O., Haughn L., Apostolou I., et al. Thymic selection revisited: how essential is it?. Immunol Rev 191 (2003) 62-78
18. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 (1986) 2348-2357
19. Hansen T., and Sachs D. The major histocompatibility complex. In: Paul W. (Ed). Fundamental immunology (1989), Raven Press, New York 445-488
20. Zika E., and Ting J.P. Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr Opin Immunol 17 (2005) 58-64
21. Magner W.J., Kazim A.L., Stewart C., Romano M.A., Catalano G., Grande C., et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol 165 (2000) 7017-7024
22. Acuto O., and Cantrell D. T cell activation and the cytoskeleton. Annu Rev Immunol 18 (2000) 165-184
23. Clements J.L., Boerth N.J., Lee J.R., and Koretzky G.A. Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu Rev Immunol 17 (1999) 89-108
24. Nagarkatti P.S., and Clark D.A. In vitro activity and in vivo correlates of alloantigen-specific murine suppressor T cells induced by allogeneic pregnancy. J Immunol 131 (1983) 638-643
25. Thomas I.K., and Erickson K.L. Gestational immunosuppression is mediated by specific Lyt 2+ T cells. Immunology 57 (1986) 201-206
26. Mincheva-Nilsson L., Hammarstrom S., and Hammarstrom M.L. Human decidual leukocytes from early pregnancy contain high numbers of gamma delta+ cells and show selective down-regulation of alloreactivity. J Immunol 149 (1992) 2203-2211
27. Ditzian-Kadanoff R., GAron J., Verp M.S., and Zilberstein M. Gamma delta T cells in human decidua. Am J Obstet Gynecol 168 (1993) 831-836
28. Heyborne K.D., Cranfill R.L., Carding S.R., Born W.K., and O'Brien R.L. Characterization of gamma delta T lymphocytes at the maternal-fetal interface. J Immunol 149 (1992) 2872-2878
29. Bonney E.A., Pudney J., Anderson D.J., and Hill J.A. Gamma-delta T cells in midgestation human placental villi. Gynecol Obstet Invest 50 (2000) 153-157
30. Barakonyi A., Polgar B., and Szekeres-Bartho J. The role of gamma/delta T-cell receptor-positive cells in pregnancy: part II. Am J Reprod Immunol 42 (1999) 83-87
31. Heyborne K., Fu Y.X., Nelson A., Farr A., O'Brien R., and Born W. Recognition of trophoblasts by gamma delta T cells. J Immunol 153 (1994) 2918-2926
32. Heyborne K.D., and Silver R.M. Immunology of postimplantation pregnancy. In: Bronson R.A., Alexander N.J., Anderson O.J., et al. (Eds). Reproductive immunology (1996), Blackwell Scientific Publications, Cambridge, MA 383-412
33. Nahmias A.J., and Kourtis A.P. The great balancing acts. The pregnant woman, placenta, fetus, and infectious agents. Clin Perinatol 24 (1997) 497-521
34. Murray D.L., Imagawa D.T., Okada D.M., and St Geme Jr. J.W. Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol 10 (1979) 184-187
35. Jones W.R., Hawes C.S., and Kemp A.S. Studies on cell-mediated immunity in human pregnancy. In: Wegmann T.G., and Gill T.J. (Eds). Immunology of reproduction (1983), Oxford University Press, New York 363-380
36. Stiehm E.R., and Fudenberg H.H. Serum levels of immune globulins in health and disease: a survey. Pediatrics 37 (1966) 715-727
37. Ballow M., Cates K.L., Rowe J.C., Goetz C., and Desbonnet C. Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 20 (1986) 899-904
38. Baker C.J., Edwards M.S., and Kasper D.L. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 68 (1981) 544-549
39. Morell A., Sidiropoulos D., Herrmann U., Romano M.A., Catalano G., Grande C., et al. IgG subclasses and antibodies to group B streptococci in preterm neonates after intravenous infusion of immunoglobulin to the mothers. Pediatr Infect Dis 5 Suppl. 3 (1986) S195-S197
40. Griffiths-Chu S., Patterson J.A., Berger C.L., Edelson R.L., and Chu A.C. Characterization of immature T cell subpopulations in neonatal blood. Blood 64 (1984) 296-300
41. Solinger A.M. Immature T lymphocytes in human neonatal blood. Cell Immunol 92 (1985) 115-122
42. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., DeLuca D., et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 89 (1992) 10006-10010
43. Wilson C.B., Westall J., Johnston L., Lewis D.B., Dower S.K., and Alpert A.R. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 77 (1986) 860-867
44. Granberg C., and Hirvonen T. Cell-mediated lympholysis by fetal and neonatal lymphocytes in sheep and man. Cell Immunol 51 (1980) 13-22
45. Sullender W.M., Miller J.L., Yasukawa L.L., Bradley J.S., Black S.B., Yeager A.S., et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis 155 (1987) 28-37 [Erratum: J Infect Dis 1987;155:838]
46. Rai R., Sacks G., and Trew G. Natural killer cells and reproductive failure - theory, practice and prejudice. Hum Reprod 20 (2005) 1123-1126
47. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
48. Koopman L.A., Kopcow H.D., Rybalov B., Boyson J.E., Orange J.S., Schatz F., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198 (2003) 1201-1212
49. Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med 200 (2004) 951-955
50. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 21 (2002) 471-495
51. Hunt J.S., Jadhav L., Chu W., Geraghty D.E., and Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 183 (2000) 682-688
52. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., and Carosella E.D. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98 (2001) 12150-12155
53. Kanai T., Fujii T., Unno N., Yamashita T., Hyodo H., Miki A., et al. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 45 (2001) 94-99
54. Hunt J.S., Fishback J.L., Chumbley G., and Loke Y.W. Identification of class I MHC mRNA in human first trimester trophoblast cells by in situ hybridization. J Immunol 144 (1990) 4420-4425
55. Yelavarthi K.K., Fishback J.L., and Hunt J.S. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J Immunol 146 (1991) 2847-2854
56. Sunderland C.A., Redman C.W., and Stirrat G.M. HLA A, B, C antigens are expressed on nonvillous trophoblast of the early human placenta. J Immunol 127 (1981) 2614-2615
57. Lata J.A., Tuan R.S., Shepley K.J., Mulligan M.M., Jackson L.G., and Smith J.B. Localization of major histocompatibility complex class I and II mRNA in human first-trimester chorionic villi by in situ hybridization. J Exp Med 175 (1992) 1027-1032
58. Hunt J.S., Fishback J.L., Andrews G.K., and Wood G.W. Expression of class I HLA genes by trophoblast cells. Analysis by in situ hybridization. J Immunol 140 (1988) 1293-1299
59. Hviid T.V., Hylenius S., Lindhard A., and Christianson O.B. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 64 (2004) 66-69
60. Rosa F., Hatat D., Abadie A., and Fellous M. Regulation of histocompatibility antigens by interferon. Ann Inst Pasteur Immunol 136C (1985) 103-119
61. Collins T., Lapierre L.A., Fiers W., Strominger J.L., and Pober J.S. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 83 (1986) 446-450
62. Zuckermann F., and Head J.R. Expression of MHC antigens on murine trophoblast and their modulation by interferon. J Immunol 137 (1986) 846-853
63. King A., Hiby S.E., Gardner L., Joseph S., Bowen J.M., Verma S., et al. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors - a review. Placenta 21 Suppl. A (2000) S81-S85
64. Holbrook K.A. Structural and biochemical organogenesis of skin and cutaneous appendages in the fetus and neonate. In: Polin R.A., and Fox W.W. (Eds). Fetal and neonatal physiology (1992), WB Saunders, Philadelphia 527-553
65. Fauser A.A., and Messner H.A. Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood 52 (1978) 1243-1248
66. Messner H.A., and Fauser A.A. Culture studies of human pluripotent hemopoietic progenitors. Blut 41 (1980) 327-333
67. Messner H.A., Izaquirre C.A., and Jamal N. Identification of T lymphocytes in human mixed hemopoietic colonies. Blood 58 (1981) 402-405
68. Kelemen E., and Janossa M. Macrophages are the first differentiated blood cells formed in human embryonic liver. Exp Hematol 8 (1980) 996-1000
69. Beelen R.H.J., van Rees E.P., and Bos H.J. Ontogeny of antigen-presenting cells. In: Chaouat G. (Ed). The immunology of the fetus (1990), CRC Press, Boca Raton, FL 110-133
70. Stiehm E.R. Fetal defense mechanisms. Am J Dis Child 129 (1975) 438-443
71. Klein R.B., Fischer T.J., GArd S.E., Biberstein M., Rich K.C., and Stiehm E.R. Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics 60 (1977) 467-472
72. Li Y., Ohls R.K., and Christensen R.D. Effects of recombinant granulocyte-macrophage colony stimulating factor on the capacity of mononuclear cells from preterm infants to generate interleukin-6 and granulocyte colony-stimulating factor. Int J Pediatr Hematol Oncol 3 (1996) 63-66
73. Forestier F., Daffos F., Galacteros F., Bardakjian J., Rainaut M., and Beuzard Y. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 20 (1986) 342-346
74. Shigeoka A.O., Santos J.I., and Hill H.R. Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. J Pediatr 95 (1979) 454-460
75. Anderson D.C., Hughes B.J., and Smith C.W. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine. J Clin Invest 68 (1981) 863-874
76. Anderson D.C., Freeman K.B., Hughes B.J., and Buffone G.J. Secretory determinants of impaired adherence and motility of neonatal PMNs. Pediatr Res 19 (1985) 257A
77. Uksila J., Lassila O., Hirvonen T., and Toivanen P. Development of natural killer cell function in the human fetus. J Immunol 130 (1983) 153-156
78. Berry S.M., Fine N., Bichalski J.A., Cotton D.B., Dombrowski M.P., and Kaplan J. Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults. Am J Obstet Gynecol 167 (1992) 895-900
79. Lubens R.G., GArd S.E., Soderberg-Warner M., and Stiehm E.R. Lectin-dependent T-lymphocyte and natural killer cytotoxic deficiencies in human newborns. Cell Immunol 74 (1982) 40-53
80. Harrison C.J., and Waner J.L. Natural killer cell activity in infants and children excreting cytomegalovirus. J Infect Dis 151 (1985) 301-307
81. Faulk W.P., and Temple A. Distribution of beta2 microglobulin and HLA in chorionic villi of human placentae. Nature 262 (1976) 799-802
82. Bulmer J.N., and Johnson P.M. Antigen expression by trophoblast populations in the human placenta and their possible immunobiological relevance. Placenta 6 (1985) 127-140
83. Redman C.W., McMichael A.L., Stirrat G.M., Sunderland C.A., and Ting A. Class I major histocompatability complex antigens on extravillus trophoblast. Immunology 52 (1984) 457-468
84. Hsi B.L., Yeh C.J., and Faulk W.P. Class I antigens of the major histocompatibility complex on cytotrophoblast of human chorion laeve. Immunology 52 (1984) 621-629
85. Hunt J.S., Lessin D.L., and King C.R. Ontogeny and distribution of cells expressing HLA-B locus-specific determinants in the placenta and extraplacental membranes. J Reprod Immunol 15 (1989) 21-30
86. Shukla H., Swaroop A., Srivastava R., and Weissman S.M. The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acids Res 18 (1990) 2189
87. Houlihan J.M., Biro P.A., Fergar-Payne A., Simpson K.L., and Holmes C.H. Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver. J Immunol 149 (1992) 668-675
88. Kirszenbaum M., Moreau P., Gluckman E., Dausset J., and Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 91 (1994) 4209-4213
89. Grusby M.J., Auchincloss Jr. H., Lee R., et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 90 (1993) 3913-3917
90. Hunt J.S., Vassmer D., Ferguson T.A., and Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 158 (1997) 4122-4128
91. Runic R., Lockwood C.J., MA Y., Dipasquale B., and Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 81 (1996) 3119-3122
92. Bamberger A.M., Schulte H.M., Thuneke I., Erdmann I., Bamberger C.M., and Asa S.L. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 82 (1997) 3173-3175
93. Kauma S.W., Huff T.F., Hayes N., and Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 84 (1999) 2188-2194
94. Hammer A., Blaschitz A., Daxbock C., Walcher W., and Dohr G. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am J Reprod Immunol 41 (1999) 41-51
95. Li W., Whaley C.D., Bonnevier J.L., Mondino A., Martin M.E., Aagaard-Tillery K.M., et al. CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation. J Immunol 167 (2001) 827-835
96. Lenschow D.J., Zeng Y., Thistlethwaite J.R., et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257 (1992) 789-792
97. Kaufman K.A., Bowen J.A., Tsai A.F., Bluestone J.A., Hunt J.S., and Ober C. The CTLA-4 gene is expressed in placental fibroblasts. Mol Hum Reprod 5 (1999) 84-87
98. Chambers C.A., Cado D., Truong T., and Allison J.P. Thymocyte development is normal in CTLA-4-deficient mice. Proc Natl Acad Sci USA 94 (1997) 9296-9301
99. Bulmer J.N., Johnson P.M., and Bulmer D. Leukocyte populations in human decidua and endometrium. In: Gill T.J., Wegmann T.G., and Nisbet-Brown E. (Eds). Immunoregulation and fetal survival (1987), Oxford University Press, New York 223-247
100. Starkey P.M., Sargent I.L., and Redman C.W. Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 65 (1988) 129-134
101. Zheng L.M., Ojcius D.M., and Young J.D. Role of granulated metrial gland cells in the immunology of pregnancy. Am J Reprod Immunol 25 (1991) 72-76
102. Kammerer U., Marzusch K., Krober S., Ruck P., Handgretinger R., and Dietl J. A subset of CD56+ large granular lymphocytes in first-trimester human decidua are proliferating cells. Fertil Steril 71 (1999) 74-79
103. Kodama T., Hara T., Okamoto E., Kusunoki Y., and Ohama K. Characteristic changes of large granular lymphocytes that strongly express CD56 in endometrium during the menstrual cycle and early pregnancy. Hum Reprod 13 (1998) 1036-1043
104. King A., Birkby C., and Loke Y.W. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 118 (1989) 337-344
105. Redman C.W.G., Ferry B.L., and Jackson M.C. Immune cell populations in human early pregnancy decidua. In: Wegmann T.F., Gill T.J., and Nisbet-Brown E. (Eds). Molecular and cellular immunobiology of the maternal-fetal interface (1991), Oxford University Press, New York 110-136
106. Guimond M.J., Luross J.A., Wang B., Terhorst C., Danial S., and Croy B.A. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod 56 (1997) 169-179
107. Guimon M.J., Wang B., and Croy B.A. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 187 (1998) 217-223
108. Guimond M., Wang B., and Croy B.A. Immune competence involving the natural killer cell lineage promotes placental growth. Placenta 20 (1999) 441-450
109. Bulmer J.N., and Sunderland C.A. Immunohistological characterization of lymphoid cell populations in the early human placental bed. Immunology 52 (1984) 349-357
110. Redline R.W., and Lu C.Y. Role of local immunosuppression in murine fetoplacental listeriosis. J Clin Invest 79 (1987) 1234-1241
111. Redline R.W., McKay D.B., Vazquez M.A., Papaioannou V.E., and Lu C.Y. Macrophage functions are regulated by the substratum of murine decidual stromal cells. J Clin Invest 85 (1990) 1951-1958
112. Chang M.D., Pollard J.W., Khalili H., Goyert S.M., and Diamond B. Mouse placental macrophages have a decreased ability to present antigen. Proc Natl Acad Sci USA 90 (1993) 462-466
113. Castellucci M., Kosanke G., Verdenelli F., Huppertz B., and Kaufman P. Villous sprouting: fundamental mechanisms of human placental development. Hum Reprod Update 6 (2000) 485-494
114. Anderson D.J., Hill J.A., Haimovici F., and Berkowitz R.S. Adverse effects of immune cell products in pregnancy. In: Wegmann T.F., Gill T.J., and Nisbet-Brown E. (Eds). Molecular and cellular immunobiology of the maternal-fetal interface (1991), Oxford University Press, New York 207-236
115. Paterson W.G., and Grant K.A. Advanced intraligamentous pregnancy. Report of a case, review of the literature and a discussion of the biological implications. Obstet Gynecol Surv 30 (1975) 715-726
116. Steven D.H., and Morris G. Development of the fetal membranes. In: Steven D.H. (Ed). Comparative placentation: essays in structure and function (1975), Academic Press, New York 58-61
117. Berkowitz R.S., Hill J.A., Kurtz C.B., and Anderson D.J. Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol 158 (1988) 199-203
118. Yui J., Garcia-Lloret M.I., Wegmann T.G., and Berkowitz R.S. In: Soares M.J., Handwerger S., and Talamantes F. (Eds). Disruption of trophoblast monolayers by TNF-alpha and IFN-gamma and antagonism by GM-CSF (1993), Serono Symposia, Boston, USA 174-179
119. Drake B.L., and Head J.R. Murine trophoblast cells are not killed by tumor necrosis factor-alpha. J Reprod Immunol 17 (1990) 93-99
120. Hill J.A., Haimovici F., and Anderson D.J. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol 139 (1987) 2250-2254
121. Hill J.A., Polgar K., Harlow B.L., and Anderson D.J. Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 166 (1992) 1044-1052
122. Hill J.A., Polgar K., and Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. J Am Med Assoc 273 (1995) 1933-1936
123. Silen M.L., Firpo A., Morgello S., Lowry S.F., and Francus T. Interleukin-1 alpha and tumor necrosis factor alpha cause placental injury in the rat. Am J Pathol 135 (1989) 239-244
124. Romero R., Mazor M., and Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 165 (1991) 969-971
125. Silver R.M., Edwin S.S., Umar F., Dudley D.J., Branch D.W., and Mitchell M.D. Bacterial lipopolysaccharide-mediated murine fetal death: the role of interleukin-1. Am J Obstet Gynecol 176 (1997) 544-549
126. Tezabwala B.U., Johnson P.M., and Rees R.C. Inhibition of pregnancy viability in mice following IL-2 administration. Immunology 67 (1989) 115-119
127. Chaouat G., menu E., Clark D.A., Dy M., Minkowski M., and Wegmann T.G. Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy. J Reprod Fertil 89 (1990) 447-458
128. Lala P.K., Scodras L.M., Graham C.H., Lysiak J.J., and Parhar R.S. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise. Cell Immunol 127 (1990) 368-381
129. Silver R.M., Lohner W.S., DAynes R.A., Mitchell M.D., and Branch D.W. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha. Biol Reprod 50 (1994) 1108-1112
130. Bone R.C. The pathogenesis of sepsis. Ann Intern Med 115 (1991) 457-469
131. Benyo D.F., Miles T.M., and Conrad K.P. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 82 (1997) 1582-1588
132. Munn D., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
133. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2 (2001) 64-68
134. Kamimura S., Eguchi K., Yonezawa M., and Sekiba K. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama 45 (1991) 135-139
135. Sedlmayr P., Blaschitz A., Wintersteiger R., Semlitsch M., Hammer A., MacKenzie C.R., et al. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol Hum Reprod 8 (2002) 385-391
136. Kudo Y., Boyd C.A., Sargent I.L., and Redman C.W. Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi. Mol Hum Reprod 6 (2000) 369-374
137. Kudo Y., Boyd C.A., Sargent I.L., and Redman C.W. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J Physiol 535 (2001) 207-215
138. Santoso D.I., Rogers P., Wallace E.M., Manuelpillai U., Walker D., and Subakir S.B. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta 23 (2002) 373-379
139. Gendron R.L., and Baines M.G. Infiltrating decidual natural killer cells are associated with spontaneous abortion in mice. Cell Immunol 113 (1988) 261-267
140. de Fougerolles A.R., and Baines M.G. Modulation of the natural killer cell activity in pregnant mice alters the spontaneous abortion rate. J Reprod Immunol 11 (1987) 147-153
141. Zuckermann F.A., and Head J.R. Susceptibility of mouse trophoblast to antibody and complement-mediated damage. Transplant Proc 17 (1985) 925-930
142. Zuckermann F., and Head J.R. Possible mechanism of non-rejection of the feto-placental allogaft: trophoblast resistance to lysis by cellular immune effectors. Transplant Proc 19 (1987) 554-556
143. Clark D.A., and Chaouat G. Characterization of the cellular basis for the inhibition of cytolytic effector cells by murine placenta. Cell Immunol 102 (1986) 43-51
144. Lu C.Y., Redline R.W., Shea C.M., Dustin L.B., and McKay D.B. Pregnancy as a natural model of allograft tolerance. Interactions between adherent macrophages and trophoblast populations. Transplantation 48 (1989) 848-855
145. Athanassakis I., Bleackley R.C., Paetkau V., Guilbert L., Barr P.J., and Wegmann T.G. The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol 138 (1987) 37-44
146. Armstrong D.T., and Chaouat G. Effects of lymphokines and immune complexes on murine placental cell growth in vitro. Biol Reprod 40 (1989) 466-474
147. Robertson S., Lavranos T., and Seamark R.F. In vitro models of the maternal-fetal interface. In: Wegmann T.F., Gill T.J., and Nisbet-Brown E. (Eds). Molecular and cellular immunobiology of the maternal-fetal interface (1991), Oxford University Press, New York 191-220
148. Bartocci A., Pollard J.W., and Stanley E.R. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med 164 (1986) 956-961
149. Pollard J.W., BArtocci A., Areci R., Orlofsky A., Ladner M.B., and Stanley E.R. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330 (1987) 484-486
150. Arceci R.J., Shanahan F., Stanley E.R., and Pollard J.W. Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci USA 86 (1989) 8818-8822
151. Wegmann T.G., Athanassakis I., Guilbert L., Branch D., Dy M., Menu E., et al. The role of M-CSF and GM-CSF in fostering placental growth, fetal growth, and fetal survival. Transplant Proc 21 (1989) 566-568
152. Fishman P., Falach-Vaknine E., Zigelman R., Bakimer R., Sredni B., Djaldetti M., et al. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 91 (1993) 1834-1837
153. Coutifaris C., Kao L.C., Sehdev H.M., Chin U., Babalola G.O., Blaschuk O.W., et al. E-cadherin expression during the differentiation of human trophoblasts. Development 113 (1991) 767-777
154. Damsky C.H., Fitzgerald M.L., and Fisher S.J. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 89 (1992) 210-222
155. Feinberg R.F., Kliman H.J., and Lockwood C.J. Is oncofetal fibronectin a trophoblast glue for human implantation?. Am J Pathol 138 (1991) 537-543
156. Dustin M.L., and Springer T.A. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 9 (1991) 27-66
157. Ohlsson R., Glaser A., Holmgren L., and Franklin G. The molecular biology of placental development. In: Redman C.W., Sargent I.L., and Starkey P.M. (Eds). The human placenta (1993), Blackwell Scientific Publications, Oxford 33
158. Choi S.J., Park J.Y., Lee Y.K., Choi H.I., Lee Y.S., Koh C.M., et al. Effects of cytokines on VEGF expression and secretion by human first trimester trophoblast cell line. Am J Reprod Immunol 48 (2002) 70-76
159. Sridama V., Pacini F., Yang S.-L., Moawad A., Reilly M., and DeGroot L.J. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med 307 6 (1982) 352-356
160. Dodson M.G., Kerman R.H., Lange C.F., Stefani S.S., and O'Leary J.A. T and B cells in pregnancy. Obstet Gynecol 49 3 (1977) 299-302
161. Siegel I., and Gleicher N. Changes in peripheral mononuclear cells in pregnancy. Am J Reprod Immunol 1 3 (1981) 154-155
162. Moore M.P., Carter N.P., and Redman C.W. Lymphocyte subsets in normal and pre-eclamptic pregnancies. Br J Obstet Gynaecol 90 4 (1983) 326-331
163. Bardeguez A.D., McNerney R., Frieri M., Verma U.L., and Tejani N. Cellular immunity in preeclampsia: alterations in T-lymphocyte subpopulations during early pregnancy. Obstet Gynecol 77 6 (1991) 859-862
164. Coulam C.B. T-lymphocyte subsets during pregnancy and the menstrual cycle. Am J Reprod Immunol 4 2 (1983) 88-90
165. Lucivero G., Selvaggi A., Dell'osso A., Antonaci S., Iannone A., Bettocchi S., et al. Mononuclear cell subpopulations during normal pregnancy: I. Analysis of cell surface markers using conventional techniques and monoclonal antibodies. Am J Reprod Immunol 4 3 (1983) 142-145
166. Tallon D.F., Corcoran D.J.D., O'Dwyer E.M., and Greally J.F. Circulating lymphocyte subpopulations in pregnancy: a longitudinal study. J Immunol 132 4 (1984) 1784-1787
167. Gill III T.J., and Repetti C.F. Immunologic and genetic factors influencing reproduction. A review. Am J Pathol 95 2 (1979) 465-570
168. Beer A. Immunology of reproduction. In: Samter M., Austen K.F., and Claman H.N. (Eds). Immunological diseases (1988), Little, Brown and Co, Boston 329
169. Gehrz R.C., Christianson W.R., Linner K.M., Conroy M.M., McCue S.A., and Balfour Jr. H.H. A longitudinal analysis of lymphocyte proliferative responses to mitogens and antigens during human pregnancy. Am J Obstet Gynecol 140 6 (1981) 665-670
170. Petrucco O.M., Seamark R.F., Holmes K., Forbes I.J., Symons R.G., et al. Changes in lymphocyte function during pregnancy. Br J Obstet Gynaecol 83 3 (1976) 245-250
171. Vaquer S., de la Hera A., Jorda J., Martinez C., Escudero M., and Alvarez-Mon M. Diminished natural killer activity in pregnancy: modulation by interleukin 2 and interferon gamma. Scand J Immunol 26 6 (1987) 691-698
172. Toder V., Nebel L., and Gleicher N. Studies of natural killer cells in pregnancy. I. Analysis at the single cell level. J Clin Lab Immunol 14 3 (1984) 123-127
173. Margoulis G.V., Buckley R.H., and Younger J.B. Serum immunoglobulin concentrations during normal pregnancy. Am J Obstet Gynecol 109 (1971) 971
174. Gonik B., Loo L.S., West S., and Kohl S. Natural killer cell cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells in human pregnancy. Am J Reprod Immunol Microbiol 13 1 (1987) 23-26
175. Kovar I.Z., and Riches P.G. C3 and C4 complement components and acute phase proteins in late pregnancy and parturition. J Clin Pathol 41 6 (1988) 650-652
176. Johnson U., and Gustavii B. Complement components in normal pregnancy. Acta Pathol Microbiol Immunol Scand [C] 95 3 (1987) 97-99